Acquisitions (Details) (USD $)	3 Months Ended			3 Months Ended		3 Months Ended
	Jun. 30, 2014	Mar. 31, 2014	Apr. 30, 2014 Hydralyte	Jun. 30, 2014 Care Pharma	Jul. 02, 2013 Care Pharma	Sep. 30, 2014 Scenario, Forecast Insight Pharmaceuticals
Business Acquisition [Line Items]
Purchase price of acquisition						$ 750,000,000
Purchase Price
Cash acquired					1,546,000
Accounts receivable					1,658,000
Inventories			1,970,000		2,465,000
Deferred income taxes					283,000
Prepaids and other current assets					647,000
Property, plant and equipment			1,267,000		163,000
Goodwill	192,632,000	190,911,000	1,224,000		23,122,000
Intangible assets			73,580,000		31,502,000
Total assets acquired			78,041,000		61,386,000
Accounts payable					1,537,000
Accrued expenses			38,000		2,788,000
Other long term liabilities			12,000		300,000
Total liabilities assumed			50,000		4,625,000
Net assets acquired			77,991,000		56,761,000
Indefinite-lived intangible assets					29,800,000
Finite-lived intangibles					$ 1,700,000
Purchased amortizable intangible assets, weighted average useful life				15 years 1 month 6 days
Amortizable intangible assets, weighted average remaining life	13 years 3 months 15 days			14 years 5 months 16 days